INTERFERON – BETA IgG MAID Test
Cost: AED 3630.0
Symptoms and Diagnosis
The INTERFERON – BETA IgG MAID Test is a diagnostic tool used to detect antibodies against interferon-beta in the blood. Interferon-beta is a naturally occurring protein that helps regulate the immune system and has been used as a treatment for various autoimmune diseases, including multiple sclerosis.
The test involves exposing a patient’s blood sample to multiple forms of interferon-beta and using a technique called immunoblotting to detect any antibodies present in the blood that bind to the interferon-beta. This test can help determine if a patient has developed antibodies against interferon-beta, which can impact the effectiveness of treatment.
The presence of interferon-beta antibodies can lead to a reduction in the drug’s efficacy and potentially increase the risk of adverse reactions. Therefore, the INTERFERON – BETA IgG MAID test is often used in clinical practice to monitor patients receiving interferon-beta therapy and to guide treatment decisions.
Test Details
- Test Name: INTERFERON – BETA IgG MAID Test
- Components: Multiple Antigenic Immunoblot Assay
- Price: AED 3630.0
- Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Collect sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
- Report Delivery: Sample by 7th of the month; Report after 2-3 weeks
- Method: Multianalyte Immunodetection (MAID)
- Test Type: Multiple Sclerosis
- Doctor: Neurologist
- Test Department: OS
- Pre Test Information: Submit sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Duly filled Test Send Out Consent Formis mandatory.
Importance of Test Results
The test results should be interpreted by a healthcare professional in conjunction with the patient’s clinical history and symptoms. The presence of interferon-beta antibodies can impact the effectiveness of treatment and potentially increase the risk of adverse reactions. Monitoring patients receiving interferon-beta therapy through the INTERFERON – BETA IgG MAID test can guide treatment decisions and ensure optimal patient care.
Test Name | INTERFERON – BETA IgG MAID Test |
---|---|
Components | |
Price | 3630.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Collect sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory. |
Report Delivery | Sample by 7th of the month; Report after 2??3 weeks |
Method | Multianalyte Immunodetection (MAID) |
Test type | Multiple Sclerosis |
Doctor | Neurologist |
Test Department: | OS |
Pre Test Information | Submit sample at least 8 hours after Interferon injection. Verify medication (Avonex, Rebif, Betaseron) and provide dose & duration of therapy. Duly filled Test Send Out Consent Formis mandatory. |
Test Details | The INTERFERON-Beta IgG MAID (Multiple Antigenic Immunoblot Assay) test is a diagnostic tool used to detect antibodies against interferon-beta in the blood. Interferon-beta is a naturally occurring protein that helps regulate the immune system and has been used as a treatment for various autoimmune diseases, including multiple sclerosis. The test involves exposing a patient’s blood sample to multiple forms of interferon-beta, and then using a technique called immunoblotting to detect any antibodies present in the blood that bind to the interferon-beta. This test can help determine if a patient has developed antibodies against interferon-beta, which can impact the effectiveness of treatment. The presence of interferon-beta antibodies can lead to a reduction in the drug’s efficacy and potentially increase the risk of adverse reactions. Therefore, the INTERFERON-Beta IgG MAID test is often used in clinical practice to monitor patients receiving interferon-beta therapy and to guide treatment decisions. It is important to note that the test results should be interpreted by a healthcare professional in conjunction with the patient’s clinical history and symptoms. |